[A new beta blocking agent: LB-46. Clinical use in the treatment of rhythm disorders and coronary insufficiency].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000517:prevention & control; D003327:Coronary Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011437:Propylamines / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D007211:Indoles; D011437:Propylamines; D013565:Sympatholytics
Un nouveau bêta-bloquant: le LB-46. Utilisation clinique dans le traitement des troubles du rythme et de l'insuffisance coronarienne.